Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study

BACKGROUND: Real-life studies are needed to determine the cost-effectiveness of asthma therapies in clinical practice. AIM: To compare the cost-effectiveness of extrafine-particle inhaled corticosteroid (ICS) with standard size-particle ICS in the United Kingdom (UK) and United States (US). METHODS:...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:NPJ Prim Care Respir Med
Auteurs principaux: Martin, Richard J, Price, David, Roche, Nicolas, Israel, Elliot, van Aalderen, Willem MC, Grigg, Jonathan, Postma, Dirkje S, Guilbert, Theresa W, Hillyer, Elizabeth V, Burden, Anne, von Ziegenweidt, Julie, Colice, Gene
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4373495/
https://ncbi.nlm.nih.gov/pubmed/25297072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npjpcrm.2014.81
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires